CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01535053
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:02.177641+00:00
Published At: 2019-08-13T00:00:00+00:00
Record Updated At: 2022-08-12
Results Posted At: 2019-08-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Choriocarcinoma", "FIGO Stage I Gestational Trophoblastic Tumor", "FIGO Stage II Gestational Trophoblastic Tumor", "FIGO Stage III Gestational Trophoblastic Tumor", "Hydatidiform Mole"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-08-12"
protocolSection.identificationModule.nctId: "NCT01535053"
protocolSection.identificationModule.officialTitle: "A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic Neoplasia"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-08-13"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.